Aspire Private Capital’s Biogen BIIB Stock Holding History

Aspire Private Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8	Closed	-$1.55K	–	211
2024 Q3	$1.55K	Hold	8	–	–	﹤0.01%	566
2024 Q2	$1.85K	Hold	8	–	–	﹤0.01%	563
2024 Q1	$1.73K	Hold	8	–	–	﹤0.01%	590
2023 Q4	$2.07K	Hold	8	–	–	﹤0.01%	560
2023 Q3	$2.06K	Hold	8	–	–	﹤0.01%	561
2023 Q2	$2.28K	Hold	8	–	–	﹤0.01%	532
2023 Q1	$2.22K	Hold	8	–	–	﹤0.01%	531
2022 Q4	$2.21K	Hold	8	–	–	﹤0.01%	517
2022 Q3	$2K	Hold	8	–	–	﹤0.01%	502
2022 Q2	$2K	Hold	8	–	–	﹤0.01%	480
2022 Q1	$2K	Hold	8	–	–	﹤0.01%	484
2021 Q4	$2K	Hold	8	–	–	﹤0.01%	505
2021 Q3	$2K	Hold	8	–	–	﹤0.01%	478
2021 Q2	$3K	Sell	8 -53	-87%	-$16.1K	﹤0.01%	444
2021 Q1	$17K	Buy	61 +50	+455%	+$13.5K	0.01%	283
2020 Q4	$3K	Hold	11	–	–	﹤0.01%	339
2020 Q3	$3K	Sell	11 -65	-86%	-$18.1K	﹤0.01%	335
2020 Q2	$21K	Buy	+76	New	+$22.8K	0.01%	189
2020 Q1	–	Sell	-8	Closed	-$2K	–	256
2019 Q4	$2K	Hold	8	–	–	﹤0.01%	364
2019 Q3	$2K	Sell	8 -1	-11%	-$233	﹤0.01%	349
2019 Q2	$2K	Hold	9	–	–	﹤0.01%	379
2019 Q1	$2K	Hold	9	–	–	﹤0.01%	421
2018 Q4	$3K	Buy	+9	New	+$2.87K	﹤0.01%	373

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aspire Private Capital's BIIB Position: Q4 2024 in Review

Aspire Private Capital sold out of Biogen (BIIB) in Q4 2024, closing a stake of 8 shares — an estimated $1.55K sold.

Aspire Private Capital first reported a position in BIIB in Q4 2018 and held it in 23 quarters. The position peaked at $21K in Q2 2020. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

Aspire Private Capital reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
Aspire Private Capital sold 8 Biogen shares in Q4 2024, an estimated $1.55K.
Aspire Private Capital first reported a position in Biogen in Q4 2018 and held it in 23 quarters.
Aspire Private Capital's Biogen position peaked at $21K in Q2 2020.
876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.